Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-050282

VP, Clinical Trial Operations sold 6,000 shares at $27.96 ($167,786)

  • VP, Clinical Trial Operations acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-20 Exercise or conversion : show line 1 in the form +6,000 $6.00 $36,000 112,135 D
2023-09-20 Sale : show line 2 in the form −6,000 $27.96 $167,786 106,135 D
Open-market sales · 6,000 sh · avg $27.96 · $167,786

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-20 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −6,000 $6.00 2029-09-20 6,000 223,253 D
Loading xslF345X05/doc4.xml…